Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
Zohra Layegh
,
Femke Hooijberg
,
Carla Bastida
,
Alwin D R Huitema
,
Theo Rispens
,
C Gertjan Wolbink
More about this publication
Clinical and experimental rheumatology
Volume
40
Issue nr.
3
Pages
664-665
Publication date
01-03-2022
Full text links
Publisher website (DOI)
10.55563/clinexprheumatol/xn5i2y
Europe PubMed Central
34796848
Pubmed
34796848